首页> 外文OA文献 >One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study

【2h】

One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study

机译：ripasudil，Rho激酶抑制剂的一年疗效和安全评估，以外或取代现有的治疗方案：回顾性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Shun Tsukahara; Nobuko Enomoto; Kyoko Ishida; Ayako Anraku; Goji Tomita;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. One-year efficacy of adjunctive use of Ripasudil, a rho-kinase inhibitor, in patients with glaucoma inadequately controlled with maximum medical therapy [J] . Inazaki Hiroshi, Kobayashi Satoshi, Anzai Yoko, Graefe's archive for clinical and experimental ophthalmology: Albrecht von Graefes Archiv fur klinische und experimentelle Opthalmologie . 2017,第10期

机译：升性的辅助使用RIPASUDIL，RHO-激酶抑制剂，青光眼患者的疗效效果，最大的医疗治疗
2. Efficacy and safety of adding ripasudil to existing treatment regimens for reducing intraocular pressure [J] . Kenji Inoue, Ryoko Okayama, Minako Shiokawa, International ophthalmology . 2018,第1期

机译：添加RIPASUDIL对现有治疗方案的功效和安全性，用于减少眼压压力
3. Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma [J] . Kusuhara Sentaro, Katsuyama Atsuko, Matsumiya Wataru, Graefe's archive for clinical and experimental ophthalmology: Albrecht von Graefes Archiv fur klinische und experimentelle Opthalmologie . 2018,第4期

机译：RIPASUDIL，R ROO相关激酶抑制剂，眼睛中的疗效和安全性
4. Inhalable Liposomes of Fasudil-a Novel Rho-Kinase Inhibitor for the Treatment of PAH [C] . Vivek Gupta, Fakhrul Ahsan Annual meeting exposition of the Controlled Release Society . 2011

机译：法舒地尔的新型可吸入脂质体-一种新型Rho激酶抑制剂，可治疗PAH
5. Addition of leukotriene receptor antagonists versus long acting beta agonists to inhaled corticosteroid therapy for asthma treatment in older adults: A retrospective data analysis of effectiveness, safety and cost. [D] . Altawalbeh, Shoroq Mahmoud. 2015

机译：在吸入性糖皮质激素治疗中，将白三烯受体拮抗剂与长效β激动剂相比，用于老年人的哮喘治疗：有效性，安全性和成本的回顾性数据分析。
6. Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study [O] . Nieves Martinez Chanza, Wanling Xie, Majd Issa, 2020

机译：免疫检查点抑制剂在已存在自身免疫性疾病的晚期泌尿外科癌症中的安全性和有效性：一项回顾性国际多中心研究
7. Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma [O] . Sentaro Kusuhara, Atsuko Katsuyama, Wataru Matsumiya, 2018

机译：RIPASUDIL，R RHO相关激酶抑制剂，眼睛在眼中的疗效和安全性

One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study

著录项

引文网络

相似文献

相关主题

期刊订阅